Ka Ting Ng

Ka Ting Ng

Auto-generated profile, based on publicly available information

Ka Ting Ng

University of Malaya, Department of Anaesthesiology, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2018 in Anaesthesia
Verified
Journal Article
Closed access
PDF file
KNK. T. Ng
K. T. Ng
CSC. J. Shubash
C. J. Shubash
JCJ. S. Chong
J. S. Chong

4 January 2019 in World Journal of Surgery
Verified
Journal Article
Closed access
PDF file
KNKa Ting Ng
Ka Ting Ng
ATAzlan Kok Vui Tsia
Azlan Kok Vui Tsia
VCVanessa Yu Ling Chong
Vanessa Yu Ling Chong

1 November 2021 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
ECEe Xin Chua
Ee Xin Chua
SZSyed Mohd Ikhmal Syed Mohd Zahir
Syed Mohd Ikhmal Syed Mohd Zahir
KNKa Ting Ng
Ka Ting Ng
WTWan Yi Teoh
Wan Yi Teoh
MHMohd Shahnaz Hasan
Mohd Shahnaz Hasan
MAMohammed F. Abosamak
Mohammed F. Abosamak


8 July 2022 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
WCWei Zhuen Chew
Wei Zhuen Chew
WTWan Yi Teoh
Wan Yi Teoh
NSNaveenaa Sivanesan
Naveenaa Sivanesan
PLPui San Loh
Pui San Loh
ISIna Ismiarti Shariffuddin
Ina Ismiarti Shariffuddin
KNKa Ting Ng
Ka Ting Ng

23 January 2020 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
KNKa T. Ng
Ka T. Ng
JYJasmine L.L. Yap
Jasmine L.L. Yap
IIIlyanna N. Izham
Ilyanna N. Izham
WTWan Y. Teoh
Wan Y. Teoh
PKPei E. Kwok
Pei E. Kwok
WKWen J. Koh
Wen J. Koh
BACKGROUND: Several studies suggest that systemic magnesium reduces postoperative opioid consumption and the intensity of pain, but others report conflicting results. The efficacy and safety profile of intravenous magnesium in noncardiac surgery remain uncertain. OBJECTIVES: The aim of this review was to investigate the effect of intravenous magnesium on the consumption of postoperative morphine in the first 24 h in adults undergoing noncardiac surgery. DESIGN: Systematic review and meta-analysis with trial sequential analysis. DATA SOURCES: MEDLINE, EMBASE, CENTRAL from their inception until January 2019. ELIGIBILITY CRITERIA: All randomised clinical trials comparing intravenous magnesium versus placebo in noncardiac surgery were systematically searched in the databases. Observational studies, case reports, case series and nonsystematic reviews were excluded. RESULTS: Fifty-one trials (n=3311) were included for quantitative meta-analysis. In comparison with placebo, postoperative morphine consumption at 24-h was significantly reduced in the magnesium group, with a mean difference [95% confidence interval (CI)] of −5.6 mg (−7.54 to −3.66, P < 0.001, I 2 = 92%, level of evidence low). The trial sequential analysis for the effect of magnesium on postoperative morphine consumption was conclusive. Patients who received magnesium had a longer time to the first analgesia request [143 (103 to 183) min, P < 0.001, I 2 = 99%, level of evidence low] and a lower incidence of shivering [0.26 (0.15 to 0.44), P < 0.001, I 2 = 35%, level of evidence very low]. However, no significance differences were demonstrated in postoperative pain scores in the first 24 h (mean difference, 95% CI) −0.30 (−0.69 to 0.09, P = 0.13, I 2 = 91%, level of evidence low), bradycardia (odds ratio, 95% CI) 1.13 (0.43 to 2.98, P = 0.80, I 2 = 35%, level of evidence very low) and postoperative nausea and vomiting (odds ratio, 95% CI) 0.90 (0.67 to 1.22, P = 0.49, I 2 = 25%, level of evidence moderate). CONCLUSION: The current meta-analysis demonstrates that the use of intravenous magnesium as part of multimodal analgesia may reduce morphine consumption in the first 24 h after surgery and delay the time to the first request for analgesia in patients undergoing noncardiac surgery. However, the included studies were of low-quality with substantial heterogeneity. TRIAL REGISTRATION: CRD42018086846.